
To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.
Esin Izat is a manager at Beghou Consulting

To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.

Following a new product’s first year on the market, there are four key ways companies can refine commercial strategies to maximize product sales.

Published: September 10th 2019 | Updated: